China Sxt Pharmaceuticals, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Ching Choon Hwa has reported beneficial ownership of 8.45% of China SXT Pharmaceuticals, Inc.'s Ordinary Shares.
NASDAQ
Tan Soo Seng has reported beneficial ownership of 8.95% of China SXT Pharmaceuticals, Inc.'s ordinary shares and associated warrants.
NASDAQ
Tan Cheng Guan has disclosed a beneficial ownership of 8.79% in China SXT Pharmaceuticals, Inc., holding over 10 million ordinary shares.
NASDAQ
Randy Foong Soon Hong has disclosed a 9.12% beneficial ownership stake in China SXT Pharmaceuticals, Inc., holding over 10.5 million ordinary shares.
NASDAQ
Streeterville Capital LLC and its affiliates have filed an amended Schedule 13G, indicating they no longer beneficially own any shares of China SXT Pharmaceuticals, Inc.